Simple blood or saliva test may predict postpartum depression in pregnancy
NCT ID NCT07186309
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new test called the Enlighten Device that uses a blood or saliva sample to predict if a pregnant woman will develop postpartum depression (PPD) after giving birth. Researchers will enroll 1,000 pregnant women and follow them for three months after delivery to see how accurate the test is. The goal is to identify women at high risk early so they can get help sooner.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION (PPD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Virginia
RECRUITINGCharlottesville, Virginia, 22903, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a wearable light device lift the fog of postpartum depression?
- Can a class tame pregnancy stress at the genetic level?
- A nationwide test: do home visits build healthier families?
- Can a simple calcium tablet help prevent postpartum bleeding?
- Can AI read ultrasound sweeps to tell Baby's position?
- Could a smart ring unlock secrets of pregnancy health?